With a team of high-skilled researchers including a number of MDs, ABOLmed conducts scientific investigations in cooperation with five institutes of the Russian Academy of Sciences and the Russian Academy of Medical Sciences. The innovative development activity of the Company allowed it to obtain 15 patents for original drug substances designed for creation of next-generation antimicrobial, anti-inflammatory and antitumor pharmaceuticals.

The firm pays great attention to the training of practicing physicians in the field of rational chemotherapy of infectious and inflammatory diseases. ABOLmed organizes and conducts educational seminars, publishes special scientific information handbooks, supports the all-Russia scientific magazine "Issues of Clinical Medicine", regularly acts as a sponsor for Russian and international medical forums.

ABOLmed is committed to creating and developing a world-class Russian pharmacological company with the purpose to address in full the needs of healthcare organizations in Russia in advanced medicines that are able to replace imported drugs, as well as to enter the international pharmacological market with proprietary solutions.